Crown Resorts Limited and Sirtex Medical Limited: 2 big earnings growers

Overseas business creates the strongest gains.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The biotechnology company Sirtex Medical Limited (ASX: SRX) made substantial gains in its business with half-year revenue up 27.2% to $58.6 million. The maker of targeted cancer treatments has been growing earnings steadily over the past two years, and in the first half of FY2014 net profit climbed 43.6% to $11.2 million.

Its sales in the Americas and Asia Pacific achieved the most growth, and total sales by dosage units have been rising by a compound annual 18.1% growth rate. Liver cancers are common now because of our eating and drinking habits, and the company’s technology allows the cancer treatment chemicals to be delivered to target cancer cells without the need for wider, more general radiation or chemotherapy.

Crown Resorts Limited (ASX: CWN), operator of the Crown casinos as well as joint owner of the City of Dreams casino in Macau, had an equally pleasing 29.4% increase in half-year underlying net profit, up to $315 million on the pcp.

A large proportion of the increase comes from the equity accounted profit of $140.6 million which it recorded from its joint venture business Melco Crown. The JV is currently expanding into other countries in South-East Asia, TO develop a new brand of integrated resorts called “City of Dreams”. The Asian market is ripe for growth as more Chinese tourists visit Macau or travel further abroad in the region. In addition, developing countries like Vietnam or the Philippines are opening up to more casino and hotel development. Japan itself, which has no major casino industry, may relax gambling legislation, giving the company and its JV another big market to potentially enter.

Foolish takeaway

Watching earnings season provides a wealth of investing ideas, but don’t just go after the ones with the biggest half-year or short-term gains. Check on the stability and consistency of earnings. Setting high targets may reduce the playing field to a small number of stocks, but the ones that remain are usually better in the long run.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

asx share price competitions represented by businessmen arm wrestling
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

person reading news on mobile phone
⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »